AMJAD ZUHIER SALEM ALROSAN

Amjad Zuhier Salem Alrosan	Assistant Professor
Pharmacology	Pharmacology
Faculty of Pharmaceutical Sciences	Department of Clinical Pharmacy and Pharmacy Practice
amjadz@hu.edu.jo
ORCID ID : 201835902
Office No. : A-435	EXT : 3435

C.V. Document file as PDF:

Ph.D.	The University of Sydney	Australia,2020
Master	Jordan University of Science and Technology	Jordan,2014
Bachelor	Jordan University of Science and Technology	Jordan,2012

A dedicated researcher with in-depth research experience and interests in Cancer Biology and Translational Oncology, Molecular and Clinical Pharmacology, and Core Mechanistic Focus: Protein Regulation and Cell Signaling. My research aims to elucidate complex molecular pathways of chronic diseases, identify novel therapeutic targets, and apply clinical and analytical methodologies to advance patient care. I possess a strong track record in publishing scientific work in peer-reviewed international journals, designing both laboratory and clinical experiments, conducting advanced statistical analysis, and leading research projects.

1)	Alrosan, K., Odeh, M., Alwidyan, T., Alrosan, A. Z., & Madae’en, S. (2025). Knowledge, attitudes, and barriers regarding health promotion of ovarian cancer among community pharmacists in Jordan. Future Science OA, 11(1). https://doi.org/10.1080/20565623.2025.2536386.

2)	Madae'en S, Dmour I, Alrosan AZ, Alwidyan T, Alrosan K, Alqhewii T, Alnsairat A, Madain R, Smadi T. Pharmacovigilance in pharmacy education: Students' knowledge, attitude and perception: A cross-sectional study in Jordan. Curr Pharm Teach Learn. 2025 Jul 18;17(11):102442. doi: 10.1016/j.cptl.2025.102442. Epub ahead of print. PMID: 40683065.

3)	Amjad Z. Alrosan, Isra Dmour, Aseel O. Rataan, Ghaith B. Heilat, Khaled Alrosan. Comparative pharmacological analysis of fam-trastuzumab deruxtecan-nxki and sacituzumab govitecan-hziy: Two recently developed chemotherapies in the crucial battle against breast cancer, Toxicology Reports Volume 14, 2025, 102054. ISSN 2214-7500. https://doi.org/10.1016/j.toxrep.2025.102054.

4)	Alrosan K, Alrosan AZ, Heilat GB, Alrousan AF, Gammoh OS, Alqudah A, Madae'En S, and Alrousan MJ: Treatment of ovarian cancer: From the past to the new era (Review). Oncol Lett 30: 384, 2025.

5)	Alrosan, A. Z., Alwidyan, T., Heilat, G. B., Rataan, A. O., & Alrosan, K. (2025). Pre-treatment red cell index and metastasis status as independent predictors of overall survival in Jordanian breast cancer patients receiving chemotherapy. Toxicology Reports, 15, 102077. https://doi.org/10.1016/j.toxrep.2025.102077

6)	Alrosan, A. Z., Alwidyan, T., Heilat, G. B., Rataan, A. O., Madae’en, S., Alrosan, K., … Ali, T. (2025). Knowledge and awareness of breast cancer signs and symptoms among Jordanian women. Future Science OA, 11(1). https://doi.org/10.1080/20565623.2025.2510871

7)	Alrosan, A.Z., Heilat, G.B., Alrosan, K. et al. NEDD4 signaling: a new frontier in the diagnosis and treatment of breast and ovarian cancers. Med Oncol 42, 200 (2025). https://doi.org/10.1007/s12032-025-02751-z

8)	Amjad Z. Alrosan, Enaam M.A. Al Momany, Ghaith B. Heilat, Khaled Alrosan, Amro K. Abu-Safieh, Suhaib A. Khuzaie, Ehab M. Alshalout. The Potential of Pharmacological Intervention Targeting NEDD4 in Glioma Heliyon, Volume 11, Issue 5, 2025, e42996, ISSN 2405-8440. https://doi.org/10.1016/j.heliyon.2025.e42996.

9)	Alrosan, A. Z., Heilat, G. B., Alrosan, K., Aleikish, A. A., Rabbaa, A. N., Shakhatreh, A. M., Alshalout, E. M., & Al Momany, E. M. A. (2024). Autonomic brain functioning and age-related health concerns. Current research in physiology, 7, 100123. https://doi.org/10.1016/j.crphys.2024.100123.

10)	Muna Oqal, Bushra Hijazi, Enaam Al Momany, Abdelrahim Alqudah, Basima A. Almomani, Amjad Z. Alrosan, Areen Alshweiat, Rasha Istaiteyeh, Roaa Alnajjar, Yazeed Bani Younes, Ro'ya Al-karra'ein, Perspective of biopharmaceutics knowledge and practice of pharmacy personnel toward the effect of medication route and medical procedure on nullifying fasting, Saudi Pharmaceutical Journal, Volume 31, Issue 9, 2023, 101747, ISSN 1319-0164, https://doi.org/10.1016/j.jsps.2023.101747.

11)	Alrosan AZ, Heilat GB, Al Subeh ZY, Alrosan K, Alrousan AF, Abu-Safieh AK, Alabdallat NS. The effects of statin therapy on brain tumors, particularly glioma: a review. Anticancer Drugs. 2023 Jul 19. doi: 10.1097/CAD.0000000000001533. Epub ahead of print. PMID: 37466094.

12)	Alrosan, A. Z., Alrosan, K., Heilat, G. B., Alsharedeh, R., Abudalo, R., Oqal, M., Alqudah, A., Elmaghrabi, Y. A."Potential roles of NEDD4 and NEDD4L and their utility as therapeutic targets in high?incidence adult male cancers (Review)". Molecular and Clinical Oncology 19.3 (2023): 68.

13)	Alqudah, A.; Qnais, E.Y.; Wedyan, M.A.; Altaber, S.; Bseiso, Y.; Oqal, M.; AbuDalo, R.; Alrosan, K.; Alrosan, A.Z.; Bani Melhim, S.; Alqudah, M.; Athamneh, R.Y.; Gammouh, O. Isorhamnetin Reduces Glucose Level, Inflammation, and Oxidative Stress in High-Fat Diet/Streptozotocin Diabetic Mice Model. Molecules 2023, 28, 502. https://doi.org/10.3390/molecules28020502

14)	Rawan H. Alsharedeh, Nida Alshraiedeh, Rawan Huwaitat, Mamduh Alqatan, Esra' O. Taybeh, Amjad Z. Alrosan, Ghaith B. Heilat. Public perceptions of the COVID-19 Pandemic: A National Cross-sectional Study. Research Journal of Pharmacy and Technology. 2022; 15(9):4119-7. doi: 10.52711/0974-360X.2022.00692

15)	Yang A*, Alrosan AZ*, Sharpe LJ, et al. Regulation of ABCG4 transporter expression by sterols and LXR ligands. Biochimica et Biophysica acta. General Subjects. 2021 Jan;1865(1):129769. DOI: 10.1016/j.bbagen.2020.129769. 
*First-Author contribution

16)	Alrosan, A., Aleidi, S.M., Yang, A., Brown, A.J. and Gelissen, I.C. The Adaptor Protein Alix is Involved in the Interaction Between the Ubiquitin Ligase NEDD4-1 and Its Targets, ABCG1 and ABCG4. Int. J. Mol. Sci. 2019; 20: 2714.

- Sep. 2024 – Present 
Assistant Dean of Accreditation and Quality Affairs, Faculty of Pharmaceutical Sciences, The Hashemite University, Zarqa, Jordan

•	Overseeing accreditation processes and quality assurance initiatives, including active membership in the Accreditation and Quality Control Committee.
•	Playing a pivotal role in preparing accreditation files for bodies like the Accreditation Council for Pharmacy Education (ACPE), including writing sections, reviewing materials, and leading ACPE-specific committees within the faculty.
•	Prepared first drafts of the Student Handbook, Faculty Handbook, and Quality Assurance Manual for the Faculty of Pharmaceutical Sciences- The Hashemite University, approved by the Dean.
•	Member of the Committee for evaluating competencies in student examinations and analyzing results.


-Sep. 2020 – Present 
Assistant Professor of Pharmacology, Faculty of Pharmaceutical Sciences, The Hashemite University, Zarqa, Jordan

•	Conducting and leading independent research projects in cancer biology, molecular pharmacology, and related therapeutic areas.
•	Publishing original research findings in reputable international peer-reviewed journals.
•	Teaching experiences in Pharmacology, Physiology, Pathophysiology, Pharmacokinetics, Drug Informatics, and Community Pharmacy Training.

Pharmacology, Physiology, Pathophysiology, Pharmacokinetics, Drug Informatics, and Community Pharmacy Training.

2012 – Present 
Jordan Pharmaceutical Association (JPA).

2018 – 2020
Australian Society for Biochemistry and Molecular Biology (ASBMB).

2019 – 2021
Australia and New Zealand Society for Cell and Developmental Biology (ANZSCDB).

 1) Primary Coordinator: Breast and Ovarian Cancers Awareness Campaign in Sama Al-Rosan/Bani Kinana and within The Hashemite University, collaborating with the Jordanian National Breast Cancer Center.

2) Extracurricular Activity Lead: Collaborated with The Hashemite University library to promote library services to faculty and students.

3)Moderator: 1st International Conference "Exploring New Frontiers in Pharmaceutical Sciences", The Hashemite University (April 2024).

4)Speaker & Organizer: Scientific day to educate females about breast and ovarian cancer signs, symptoms, risk factors, and importance of regular screening. Sama Alrosan, Irbid, Jordan (October 29, 2022).

5)Faculty Trainer: Workshop on pill swallowing (avoiding dysphagia) for students at Hashemite University's Pharmacy Management and Pharmaceutical Care Innovation Center, in collaboration with Liverpool John Moores University/School of Pharmacy (November 29, 2021).

6)Poster presentation: Alrosan A., Aleidi S.M., Yang A., Brown A.J. and Gelissen I.C. The Adaptor Protein Alix is Involved in the Interaction Between the Ubiquitin Ligase NEDD4-1 and Its Targets, ABCG1 and ABCG4. ANZSCDB Annual General Meeting, (2nd-4th Oct, 2019), Adelaide, NSW, Australia.

7)Poster presentation:  Amjad Z. Alrosan, Shereen M. Aleidi, Alryel Yang, Andrew J. Brown, and Ingrid C. Gelissen. The Adaptor Protein Alix is Involved in the Interaction Between the Ubiquitin Ligase NEDD4-1 and Its Targets, ABCG1 and ABCG4. Oral Presentation, (2nd Oct, 2019), Sydney, NSW, Australia.

8)Poster presentation:  Alrosan, A., Aleidi, S.M., Yang, A., Brown, A.J., Gelissen, I.C. Is Alix a cofactor/adaptor for ABCG1/ABCG4 and NEDD4-1?. FMH 2018 Scientific Meeting, (7th Dec, 2018), Sydney, NSW, Australia.

9)Poster presentation: Amjad Z. Alrosan, Shereen M. Aleidi, Alryel Yang, Andrew J. Brown, and Ingrid C. Gelissen. Is Alix a cofactor/adaptor for ABCG1/ABCG4 and NEDD4-1? Postgraduate Conference 2018 (26th -27th Sep. 2018), Sydney, NSW, Australia.

10)Poster presentation: Alrosan, A., Aleidi, S.M., Yang, A., Brown, A.J., Gelissen, I.C. Is Alix a cofactor/adaptor for ABCG1/ABCG4 and NEDD4-1?. ComBio conference, (23rd -26th Sep. 2018), Sydney, NSW, Australia.

AMJAD ZUHIER SALEM ALROSAN

AMJAD ZUHIER SALEM ALROSAN

Welcome to the Hashemite University faculty staff website.